A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas
NCT00974129 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2014-06-24
Summary
The purpose of this study is to evaluate the genotype of CTCF, a proven transcription factor, in patients with infantile hemangiomas and to monitor tumor growth. The investigators aim to determine whether or not the CTCF genotype might serve as an early and reliable predictor of tumor growth.
Conditions
- Hemangioma
Sponsors & Collaborators
-
Yale University
lead OTHER
Principal Investigators
-
Deepak Narayan, MD · Yale University
Eligibility
- Max Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2012-06-30
- Completion
- 2012-06-30
Countries
- United States
Study Locations
More Related Trials
-
Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk
NCT07142772 ·Status: NOT_YET_RECRUITING
-
Deep Learning Magnetic Resonance Imaging Radiomics for Diagnostic Value of Hepatic Tumors in Infants
NCT05170282 ·Status: UNKNOWN
-
Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children
NCT05406947 ·Status: NOT_YET_RECRUITING
-
Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1
NCT05238909 ·Status: ENROLLING_BY_INVITATION
-
Psychosocial Situation of Children With Rare Solid Abdominal Tumors and Their Families
NCT05245123 ·Status: COMPLETED
-
Study of Stored Tumor Samples in Young Patients With Brain Tumors
NCT00897286 ·Status: TERMINATED
-
Arterial Spin Labeling Perfusion Magnetic Resonance (MR) Imaging in Pediatric Brain Tumors
NCT00907244 ·Status: COMPLETED
-
Molecular and Cellular Characterization of Skull Base Tumors
NCT03759717 ·Status: RECRUITING
-
Stereo Photogrammetry Imaging in Normal Volunteers and Patients With Head and Facial Malformations
NCT00100529 ·Status: COMPLETED
-
Utility of PET-MRI in Surveillance of Paediatric Brain Tumours
NCT05553899 ·Status: RECRUITING ·Phase: NA
-
Integrated PET/MRI and Germline Variants to Differentiate Brain Tumopr Recurrence From Iatrogenicchanges in Children
NCT06226519 ·Status: RECRUITING
-
Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
NCT00060008 ·Status: TERMINATED ·Phase: NA
-
Study of the Effect of GM-CSF on Macrophages in Ependymoma
NCT04408092 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors
NCT00897858 ·Status: WITHDRAWN
-
Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
NCT00258453 ·Status: COMPLETED ·Phase: NA
-
The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids
NCT03993210 ·Status: TERMINATED ·Phase: NA
-
Stem Cells in NF1 Patients With Tumors of the Central Nervous System
NCT03332030 ·Status: WITHDRAWN
-
Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children
NCT05179850 ·Status: UNKNOWN
-
Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease
NCT00005902 ·Status: ACTIVE_NOT_RECRUITING
-
PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)
NCT01800032 ·Status: COMPLETED
-
Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1
NCT03820778 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
NCT01222728 ·Status: COMPLETED
-
Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients
NCT02095353 ·Status: TERMINATED
-
Characterization of At-risk Population for Pre-sacral Tumor in CURRARINO Syndrome
NCT00780117 ·Status: COMPLETED
-
Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma
NCT00897611 ·Status: COMPLETED ·Phase: NA